Role of α- and β-Synucleins in the Axonal Pathology of Parkinson’s Disease and Related Synucleinopathies

by Akio Sekigawa, Yoshiki Takamatsu, Kazunari Sekiyama, Makoto Hashimoto
Published 2015-05-01

Adiponectin paradox as a therapeutic target of the cancer evolvability in aging

by Yoshiki Takamatsu, Gilbert Ho, Ryoko Wada, Satoshi Inoue, Makoto Hashimoto
Published 2021-01-01

Possible Alterations in β-Synuclein, the Non-Amyloidogenic Homologue of α-Synuclein, during Progression of Sporadic α-Synucleinopathies

by Makoto Hashimoto, Kazunari Sekiyama, Akio Sekigawa, Masayo Fujita, Yoshiki Takamatsu
Published 2012-09-01

Possible Role of Amyloidogenic Evolvability in Dementia with Lewy Bodies: Insights from Transgenic Mice Expressing P123H β-Synuclein

by Masayo Fujita, Gilbert Ho, Yoshiki Takamatsu, Ryoko Wada, Kazutaka Ikeda, Makoto Hashimoto
Published 2020-04-01

α-Synuclein and DJ-1 as Potential Biological Fluid Biomarkers for Parkinson’s Disease

by Makoto Hashimoto, Masayo Fujita, Yoshiki Takamatsu, Akio Sekigawa, Kazunari Sekiyama, Masaaki Waragai
Published 2010-10-01

Therapeutic Potential of αS Evolvability for NeuropathicGaucher Disease

by Jianshe Wei, Yoshiki Takamatsu, Ryoko Wada, Masayo Fujita, Gilbert Ho, Eliezer Masliah, Makoto Hashimoto
Published 2021-02-01

Adiponectin Paradox in Alzheimer's Disease; Relevance to Amyloidogenic Evolvability?

by Masaaki Waragai, Gilbert Ho, Yoshiki Takamatsu, Ryoko Wada, Shuei Sugama, Takato Takenouchi, Eliezer Masliah, Makoto Hashimoto
Published 2020-03-01

Connecting Alzheimer’s Disease With Diabetes Mellitus Through Amyloidogenic Evolvability

by Gilbert Ho, Yoshiki Takamatsu, Ryoko Wada, Shuei Sugama, Masaaki Waragai, Takato Takenouchi, Eliezer Masliah, Makoto Hashimoto
Published 2020-10-01

Diversity of Mitochondrial Pathology in a Mouse Model of Axonal Degeneration in Synucleinopathies

by Akio Sekigawa, Yoshiki Takamatsu, Kazunari Sekiyama, Takato Takenouchi, Shuei Sugama, Masaaki Waragai, Masayo Fujita, Makoto Hashimoto
Published 2013-01-01

Neuroinflammation in Parkinson's Disease and Related Disorders: A Lesson from Genetically Manipulated Mouse Models of α-Synucleinopathies

by Kazunari Sekiyama, Shuei Sugama, Masayo Fujita, Akio Sekigawa, Yoshiki Takamatsu, Masaaki Waragai, Takato Takenouchi, Makoto Hashimoto
Published 2012-01-01

Combined immunotherapy with “anti-insulin resistance” therapy as a novel therapeutic strategy against neurodegenerative diseases

by Yoshiki Takamatsu, Gilbert Ho, Wakako Koike, Shuei Sugama, Takato Takenouchi, Masaaki Waragai, Jianshe Wei, Kazunari Sekiyama, Makoto Hashimoto
Published 2017-01-01

Motor and Nonmotor Symptoms of Parkinson’s Disease: Antagonistic Pleiotropy Phenomena Derived from α-Synuclein Evolvability?

by Yoshiki Takamatsu, Masayo Fujita, Gilbert J. Ho, Ryoko Wada, Shuei Sugama, Takato Takenouchi, Masaaki Waragai, Eliezer Masliah, Makoto Hashimoto
Published 2018-01-01